ADCs for Advanced BC
Integration of Novel Antibody–Drug Conjugates in Advanced HER2-Low, Hormone Receptor–Positive, and Triple-Negative Breast Cancer

Released: November 13, 2024

Expiration: November 12, 2025

Komal Jhaveri
Komal Jhaveri, MD, FACP
Melinda Telli
Melinda Telli, MD
Sara M. Tolaney
Sara M. Tolaney, MD, MPH

Activity

Progress
1
Course Completed